Upstream Launches With $200m To Buy, Develop Drugs For Immune-Mediated Diseases

Lead Drug Candidate Targets TSLP Receptor For Asthma, Other Indications

 
• By Mandy Jackson
  
Lung health vector illustration
Upstream is focused on immune-mediated diseases, including asthma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business